Hong Kong’s own drug regulator pushes ahead with hiring, seeks WHO recognition

As Hong Kong marks the 29th anniversary of its return to Chinese rule on July 1, the China-morning-post" class="entity-link entity-organization" data-entity-id="12558" data-entity-type="organization">South China Morning Post talks to the city’s senior officials about the administration’s achievements so far and what may lie ahead.Hong Kong is on a global talent hunt for its own drug approval body which is expected to be launched by the fourth quarter of this year as the city bids to achieve its international biomedical hub ambitions, the city’s health minister has revealed.In an exclusive interview with the China-morning-post" class="entity-link entity-organization" data-entity-id="12558" data-entity-type="organization">South China Morning Post, Secretary for Health Lo Chung-mau said the government was in talks with its mainland Chinese counterpart to seek World Health Organization recognition for the city’s future Centre for Medical Products Regulation (CMPR), a crucial step towards establishing the body as an internationally recognised primary drug evaluator.